Hedge Funds Hold Significant Stake in Whitehawk Therapeutics, Inc. (NASDAQ:WHWK)

Hedge funds own a significant 37% stake in Whitehawk Therapeutics, with the top 7 shareholders holding 52% of the business. Institutional investors, particularly hedge funds, can significantly impact the stock price through their trading decisions. Analyzing ownership data can help assess a company's future performance, especially in the biotech industry where institutional ownership is significant.